Unmet clinical need
The GM AHSN believes that addressing validated clinical needs provides a ?clinical pull? for new products and services that are required by the NHS.
This constitutes a ?demand led? approach to solving healthcare problems and also provides a ?willing consumer? for new goods and services, providing companies with a better chance of successful purchase and adoption by the NHS.
The validation of clinical need will be part of the service provided by theÿGM AHSN advisor teamÿwhen a company submits a request for assistance from the GM AHSN.
In addition to validating enquiries for supportÿon the basis of clinical need, the GM AHSN has already initiated aÿTechnology Innovation Challenge fund, seeking to support technology developments in the GM AHSN’s clinicalÿpriority areas, which demonstrates theÿGM AHSN’s commitment to supportingÿnew and innovative approaches to addressing problems in key areas of unmet need.